These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16227781)

  • 1. Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART.
    Delobel P; Sandres-Sauné K; Cazabat M; L'Faqihi FE; Aquilina C; Obadia M; Pasquier C; Marchou B; Massip P; Izopet J
    AIDS; 2005 Nov; 19(16):1739-50. PubMed ID: 16227781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lymphocyte HIV reservoir in patients on long-term HAART is a memory of virus evolution.
    Lambotte O; Chaix ML; Gubler B; Nasreddine N; Wallon C; Goujard C; Rouzioux C; Taoufik Y; Delfraissy JF
    AIDS; 2004 May; 18(8):1147-58. PubMed ID: 15166530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular evidence for drug-induced compartmentalization of HIV-1 quasispecies in a patient with periodic changes to HAART.
    Wang YM; Dyer WB; Workman C; Wang B; Sullivan JS; Saksena NK
    AIDS; 2000 Oct; 14(15):2265-72. PubMed ID: 11089614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART.
    Baldanti F; Paolucci S; Gulminetti R; Maserati R; Migliorino G; Pan A; Maggiolo F; Comolli G; Chiesa A; Gerna G
    Antiviral Res; 2001 Jun; 50(3):197-206. PubMed ID: 11397507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of total and integrated HIV-1 DNA in peripheral CD4 lymphocytes and monocytes after long treatment with HAART.
    Calcaterra S; Cappiello G; Di Caro A; Garbuglia AR; Benedetto A
    J Infect; 2001 Nov; 43(4):239-45. PubMed ID: 11869061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy.
    Valentin A; Rosati M; Patenaude DJ; Hatzakis A; Kostrikis LG; Lazanas M; Wyvill KM; Yarchoan R; Pavlakis GN
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7015-20. PubMed ID: 12011460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
    J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells.
    Sahu GK; Paar D; Frost SD; Smith MM; Weaver S; Cloyd MW
    J Med Virol; 2009 Jan; 81(1):9-15. PubMed ID: 19031450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy.
    Sonza S; Mutimer HP; Oelrichs R; Jardine D; Harvey K; Dunne A; Purcell DF; Birch C; Crowe SM
    AIDS; 2001 Jan; 15(1):17-22. PubMed ID: 11192864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.
    Clerici M; Seminari E; Suter F; Castelli F; Pan A; Biasin M; Colombo F; Trabattoni D; Maggiolo F; Carosi G; Maserati R
    AIDS; 2000 Jan; 14(2):109-16. PubMed ID: 10708280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
    Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
    J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamic changes of cellular HIV-1 DNA quantification during highly active antiretroviral therapy in Chinese HIV infected individuals].
    Chen X; Zheng Y; Mamadou D; He Y; Zhou H; Chen Z; Luo Y; He B; He M; Yao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):537-44. PubMed ID: 23719535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy.
    Raymond S; Saliou A; Delobel P; Cazabat M; Pasquier C; Jeanne N; Sauné K; Massip P; Marchou B; Izopet J
    J Antimicrob Chemother; 2014 Sep; 69(9):2527-30. PubMed ID: 24840625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of replication-competent virus from CD4 T cell reservoirs and change in coreceptor use in human immunodeficiency virus type 1-infected children responding to highly active antiretroviral therapy.
    Equils O; Garratty E; Wei LS; Plaeger S; Tapia M; Deville J; Krogstad P; Sim MS; Nielsen K; Bryson YJ
    J Infect Dis; 2000 Sep; 182(3):751-7. PubMed ID: 10950768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy.
    Persaud D; Ray SC; Kajdas J; Ahonkhai A; Siberry GK; Ferguson K; Ziemniak C; Quinn TC; Casazza JP; Zeichner S; Gange SJ; Watson DC
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):381-90. PubMed ID: 17411371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.
    Otero M; Nunnari G; Leto D; Sullivan J; Wang FX; Frank I; Xu Y; Patel C; Dornadula G; Kulkosky J; Pomerantz RJ
    AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1097-103. PubMed ID: 14709246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia.
    Wendland T; Furrer H; Vernazza PL; Frutig K; Christen A; Matter L; Malinverni R; Pichler WJ
    AIDS; 1999 Oct; 13(14):1857-62. PubMed ID: 10513643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of replication-competent HIV in both memory and naive CD4 T cell subsets in patients on prolonged and effective HAART.
    Lambotte O; Demoustier A; de Goër MG; Wallon C; Gasnault J; Goujard C; Delfraissy JF; Taoufik Y
    AIDS; 2002 Nov; 16(16):2151-7. PubMed ID: 12409736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.